HOME >> MEDICINE >> NEWS
Most comprehensive USA clinical trial to date shows competing medicated stents work equally well

After completing the most comprehensive U.S.-based study of its kind, Dr. Charles Simonton reported that the performance of two competing coronary stents was "virtually identical" in head-to-head comparisons.

Simonton, a cardiologist associated with the Carolinas Heart Institute at Carolinas Medical Center, summarized his conclusions at the annual TCT (Transcatheter Cardiovascular Therapeutics) meeting in Washington DC. TCT is recognized as the world's largest scientific symposium for healthcare professionals dedicated to interventional and vascular therapy.

Coronary care specialists have known for several years that so called "drug-eluting stents" outperform bare-metal stents in preventing the recurrence of blockage in coronary arteries repaired via angioplasty.

However, only two manufacturers produce drug-eluting stents, which are utilized in more than 750,000 coronary procedures annually, and study results have varied on whether one brand was more effective than the other.

The STENT registry, which now includes approximately 14, 000 patients, is the first of its kind to gather data from multiple sites, including eight medical centers located throughout the Southeast. The registry also includes one of the largest patient follow-up efforts based on a profile of the general populace. Earlier clinical trials focused on patient populations carefully screened to exclude high risk cases.

Since drug-eluting stents were first approved by the FDA in May 2003, follow up comparisons have varied for Taxus, manufactured by Boston Scientific, and Cypher, manufactured by Cordis Corp., a subdivision of Johnson & Johnson.

The new study, which involves non-proprietary research, shows outcomes the same for TVR (target vessel re-vascularization) and MACE (major adverse cardiac events, such as myocardial infarction, stroke or death, following interventional treatment).

The STENT registry is a partnership of the Dickson Institu
'"/>

Contact: Raymond C. Jones
raymond.jones@carolinas.org
704-355-3141
Carolinas HealthCare System
25-Oct-2005


Page: 1 2

Related medicine news :

1. Amgen introduces comprehensive financial assistance programs for cancer patients
2. Diabetes program demonstrates comprehensive care approach to NYC participants
3. Only transplant center that developed comprehensive protocol for liver transplants in kids with MSUD
4. Northwestern Memorial neurologist is lead author of comprehensive stroke center recommendations
5. New contracts support clinical trials on antibiotic-resistant, community-acquired staph infections
6. Damon Runyon renews its $2.25 million investment to support young clinical cancer investigators
7. International journal group updates guidelines on registration of clinical trials
8. Urgent need for guidance on mobile phone use in clinical care
9. New prostate cancer clinical guidelines to be released
10. First clinical trial of gene therapy for childhood blindness
11. Acute coronary syndrome therapy improvements linked with fewer deaths and improved clinical outcomes

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/27/2017)... ... ... Team Novo Nordisk, the world’s first all-diabetes professional cycling team, is bringing Isle ... the remainder of the 2017 season. One of our best development riders, Brand is ... , “Every season we are excited to move an athlete from our pipeline up ...
(Date:7/26/2017)... (PRWEB) , ... July 26, 2017 , ... Capillus, LLC ... treat hereditary hair loss. The new Flexible Fitting Design offers a more comfortable, adaptable ... LLC is delighted with the improvements to the home-use laser therapy caps intended to ...
(Date:7/26/2017)... ... July 26, 2017 , ... A major challenge many labs face is ... samples and a lengthy freeze dry cycle are a few common challenges that can ... as well as new accessories and advancements in laboratory freeze dryers that will improve ...
(Date:7/26/2017)... ... 2017 , ... It's time to sign up for the new One-A-Month Essential Oil ... Heshelow, founder of Sublime Naturals and author of numerous books on essential oils. , ... by the 5th. , Two items are included in the December mailing. ...
(Date:7/26/2017)... Jupiter, Florida (PRWEB) , ... July 26, 2017 ... ... care for dogs and cats has opened in Jupiter. The state of ... patients (cardiology) and class leading treatments with a goal of providing heart patients ...
Breaking Medicine News(10 mins):
(Date:7/26/2017)... 2017 Sancilio Pharmaceuticals Company, Inc. (SPCI) today ... evaluating Altemia TM , an oral therapy for pediatric ... Disease (SCD). The SCOT Trial, is a double-blind, placebo-controlled, ... of Altemia TM in pediatric patients aged 5-17 ... 125274. "The completion ...
(Date:7/24/2017)... Mich. , July 24, 2017  Diplomat Pharmacy, ... it will release its second quarter 2017 operating results ... a conference call to follow at 5:00 p.m. ET. ... participants may listen to a live broadcast of the ... callers, and referencing participant code 51641230 approximately 15 minutes ...
(Date:7/20/2017)... , July 20, 2017  Prime Therapeutics LLC (Prime) released ... , M.D., following today,s Institute for Clinical and Economic Review,s ... on the effectiveness and value of abuse-deterrent formulations (ADF) of ... policy roundtable at the meeting. ... material cost benefit to the use of abuse-deterrent formulations (ADF) ...
Breaking Medicine Technology:
Cached News: